Brahmi Vati

Brahmi Vati is an Ayurvedic herbal formulation (vati = tablet/pill) rather than a whole food ingredient, so conventional macronutrient profiling is not applicable in the traditional sense. The formulation is primarily composed of Bacopa monnieri (Brahmi) as the principal ingredient, along with classical adjuvants. Key bioactive compounds include: Bacosides A and B (primary saponin glycosides, approximately 20-55% standardized extract concentration in quality preparations), responsible for neurotrophic and nootropic activity; Bacopasaponins C, D, E, and F (minor saponins contributing synergistic effects); Alkaloids including Brahmine (~0.3 mg/g dry weight) and Herpestine (~0.2 mg/g dry weight); Phytosterols including beta-sitosterol (~1.2-1.8 mg/g); Flavonoids including Luteolin and Apigenin (~0.8-1.2 mg/g combined); D-mannitol (~2-3% w/w); Betulinic acid (triterpenoid, trace concentrations ~0.1 mg/g); and Hersaponin (alkaloid saponin with mild sedative properties). The formulation typically contains binders and classical Ayurvedic excipients including purified Parada (mercury-based in some traditional forms, now largely replaced with safer substitutes) and Abhraka Bhasma (mica ash, providing silica and trace minerals). Protein content is negligible (<1% w/w). Fiber content is minimal (~2-4% w/w from plant matrix. Bioavailability note: Bacosides exhibit moderate oral bioavailability (~40-55%), significantly enhanced when taken with fat-containing foods or milk (traditional recommendation), as the saponin glycosides are lipophilic. Peak plasma concentration occurs at approximately 2-3 hours post-ingestion. Standard therapeutic dose ranges from 125-500 mg per tablet, typically administered 1-2 tablets twice daily.